![]() |
|
|
Vol. 29, Issue 7, 1007-1012, July 2001
| |
Abstract |
|---|
|
|
|---|
Serum from humans with an upper respiratory viral infection (HSURVI) and from rabbits with a turpentine-induced acute inflammatory reaction (RSTIAR) reduces the activity of hepatic cytochrome P450 (P450) following 4 h of incubation. The aim of the present study was to assess the effect of HSURVI and RSTIAR on P450 activity and expression following 24 h of incubation with hepatocytes from control (HCONT) and rabbits with a TIAR (HINFLA). RSTIAR incubated with HCONT for 24 h reduced P450 content and activity, and CYP3A6 by 45%, without changing CYP1A1 and 1A2; when incubated with HINFLA, RSTIAR decreased P450 content and activity without affecting CYP1A1 or 1A2. HSURVI incubated for 4 h with HCONT decreased P450 activity without affecting the amounts of CYP1A1, 1A2, or 3A6, although when incubated for 24 h, P450 activity and CYP3A6 amount decreased. HSURVI incubated with HINFLA for 4 h reduced P450 content and activity, and incubated for 24 h reduced activity, P450 content, and amount of CYP1A1 and 1A2 proteins. The present study demonstrates that 1) the effect of RSTIAR and HSURVI depends upon the susceptibility of the hepatocyte, i.e., HCONT or primed HINFLA; 2) P450 down-regulation is preceded by a decrease in P450 activity; 3) the nature of the inflammatory reaction determines the repercussions on P450 activity and expression; and 4) CYP3A6 is more vulnerable than CYP1A1 and 1A2 to the down-regulation provoked by an inflammatory challenge.
| |
Introduction |
|---|
|
|
|---|
In human, viral and bacterial infections as well as influenza and
BCG vaccinations decrease the clearance of exogenous substances such as
theophylline and antipyrine, secondary to a decrease in activity of
multiple isoforms of the cytochrome P450
(P4501)
(Morgan, 1997
). As a consequence, bacterial and viral inflammatory reactions are cause of severe drug toxicity, essentially in pediatric and geriatric populations (Hendeles et al., 1977
; Ziment, 1982
; Koren
and Greenwald, 1985
). In animal models, infectious and noninfectious acute inflammatory reactions, such as those induced by endotoxin and
turpentine, also diminish the rate of metabolism of xenobiotics (Parent
et al., 1992
; Morgan, 1997
).
In response to viral infections, the concentration in blood of many
cytokines is increased (Ramshaw et al., 1997
). It has been assumed that
in vivo cytokines are responsible for P450 depression because in vitro
cytokines can depress multiple hepatic P450 isoforms and their mRNAs.
For instance, INF-
depresses CYP1A2, 2A6, 2B6, and 3A4; IL-6
depresses CYP1A1, 1A2, 2D, 3A4, and 4A1; and IL-1
down-regulates
1A2, 2C11, 2D6, 2E1, and 3A (Fukuda et al., 1992
; Trautwein et al.,
1992
; Donato et al., 1997
; Parmentier et al., 1997
). Furthermore, it
has been reported that IFN-
(Stanley et al., 1991
), IL-1 (Peterson
and Renton, 1986
), and TNF-
(Paton and Renton, 1998
) can also reduce
the activity of several P450 isoforms.
In vitro, following an incubation period of 4 h with hepatocytes,
serum from humans with an upper respiratory tract viral infection
(HSURVI) and serum from rabbits with a
turpentine-induced acute inflammatory reaction
(RSTIAR) decreases the activity of CYP1A1 and 1A2
without affecting the amount of these proteins (El-Kadi et al., 1997
).
The mediators responsible for the decrease in P450 activity are
IFN-
, IL-6, and IL-1
in HSURVI, and IL-6 in
RSTIAR (Bleau et al., 2000
), demonstrating that
in vivo, infectious, and noninfectious inflammatory reactions generate
serum mediators, namely, cytokines, capable to reduce P450 activity.
Since in vivo, an inflammatory reaction depresses the expression of
multiple isoforms of the P450, it was of interest to establish whether
HSURVI and RSTIAR are
capable to down-regulate the expression of selected P450 isoforms in
hepatocytes. Specifically, the aims of the present study were 1) to
assess the effect of RSTIAR and HSURVI on the activity and expression of hepatic
CYP1A1, 1A2, and 3A6 following 24-h incubation periods; and 2) to
compare the differences in effect between RSTIAR
and HSURVI as a function of the source of the
hepatocytes, i.e., hepatocytes harvested from control rabbits
(HCONT) and hepatocytes from rabbits with a TIAR
(HINFLA). The use of HINFLA
was justified because the density of surface receptors to cytokines is
greater than in HCONT (Dinarello, 1994
).
Theophylline was used to assess the activity of some isoforms of the
P450. In the rabbit, theophylline is primarily metabolized by CYP1A2
and CYP1A1, and to a minor degree by CYP3A6; CYP1A1, and CYP1A2 both
contribute to the formation of theophylline three metabolites
3-methylxanthine (3 MX), 1-methyluric acid (1 MU), and 1,3-dimethyluric
acid (1,3DMU) (Kurdi et al., 1999
).
| |
Materials and Methods |
|---|
|
|
|---|
Collection of Hepatocytes and Serum from Rabbits.
Male New Zealand White rabbits (1.8-2.2 kg) were obtained from Ferme
Charles Rivers (St-Constant, Québec, Canada). A local inflammatory reaction was induced by the s.c. injection of 5 ml of
turpentine (Recochem, Montréal, Québec) distributed into four distinct sites of the back of the rabbits. Forty-eight hours later, blood (20 ml) was withdrawn from the central artery of an ear of
the rabbits, controls and with a TIAR; the rabbits were anesthetized,
and hepatocytes were isolated. Blood samples were allowed to clot at
room temperature for 2 h, centrifuged at 2500 rpm for 5 min, and
the serum was decanted and stored frozen at
20°C in 1-ml aliquots
until use. The severity of the inflammatory reaction was assessed by
measuring serum concentrations of seromucoids (Parent et al., 1992
).
All the experiments were conducted according to the Canadian Council on
Animal Care guidelines for use of laboratory animals.
Collection Serum from Humans.
Blood (10 ml) was withdrawn from humans (n = 8) with an
inflammatory reaction secondary to an upper respiratory viral
infection, at the apex of clinical symptomatology, i.e., 24 h
after the appearance of overt manifestations of an upper respiratory
tract viral infection, such as rhinorrhea, sneezing, nasal congestion,
sore throat, cough, and systemic signs of malaise, including fever, in
absence of purulent secretions. Blood samples were allowed to clot at
room temperature for 2 h, centrifuged at 2500 rpm for 5 min, and
the serum was decanted and stored frozen at
20°C in 1-ml aliquots until use.
Cytochrome P450 Content and Activity.
The efficacy of the serum to reduce hepatic P450 content was tested by
incubating 200 µl of serum with 2 ml/well of
HCONT and HINFLA for 4 and
24 h. Hepatic P450 content, evaluated by its ability to bind
carbon monoxide, was measured spectrophotometrically as described by
Omura and Sato (1964)
. Protein content in hepatocytes was measured by
the method of Lowry et al. (1951)
.
20°C until analysis of theophylline and its metabolites by high-performance liquid chromatography (du Souich et al., 1989Western Blot Analysis.
Proteins were separated by SDS-polyacrylamide gel electrophoresis
(7.5% polyacrylamide) under nonreducing conditions (Smith, 1994
).
Proteins were electrophoretically transferred to a nitrocellulose membrane using a semidry transfer process (Bio-Rad, Hercules, CA).
CYP1A1 and 1A2 proteins were detected with a polyclonal anti-rabbit CYP1A1, and visualized with an alkaline phosphatase-conjugated secondary goat antibody using nitro blue tetrazolium as the substrate (Kruger, 1994
). CYP3A6 protein was detected with a monoclonal anti-rat
CYP3A1 and a horseradish peroxidase-conjugated secondary antibody;
chemiluminescence was visualized by autoradiography (Thorpe et al.,
1985
). The intensities of the bands were measured with a software
Un-Scan-It-Gel (Silk Scientific Inc., Orem, UT).
Drugs and Chemicals. The Percoll gradient, Williams' medium E, calf serum, type I rat tail collagen, NaCl, KCl, KH2PO4, HEPES, EGTA, glucose, theophylline, 3 MX, 1 MU, and 1,3DMU were purchased from Sigma (St. Louis, MO) and insulin was from Roche Molecular Biochemicals (Mannheim, Germany).
Statistical Analysis. All data are reported as means ± S.E. The comparison of the results from the various experimental groups and their corresponding controls was carried out using a one-way analysis of variance followed by Newman-Keuls post hoc test. The effect of RSTIAR and HSURVI on the amount of CYP1A1, 1A2, and 3A6 (densitometry values) was compared with the effect of RSCONT and HSCONT by using a paired t test. The differences were considered significant when p < 0.05.
| |
Results |
|---|
|
|
|---|
Effect of a TIAR on P450 Content, Activity, and Amount of P450 Apoproteins. Total P450 content in HCONT was 0.284 ± 0.014 nmol/mg of protein, a value that was reduced to 0.152 ± 0.012 nmol/mg of protein in HINFLA (p < 0.05). Compared with HCONT, when theophylline was incubated for 4 h with HINFLA, the formation of 1,3DMU, 3 MX, and 1 MU was reduced by 43, 85, and 43%, respectively (p < 0.005), reflecting essentially a decrease in CYP1A1 and 1A2 activity (Table 1). After 24 h of incubation, the formation of 1,3DMU, 3 MX, and 1 MU was reduced by a percentage similar to that reported after 4-h incubation (data not shown). Compared with HCONT, the TIAR diminished the amount of CYP1A1 by 47%, i.e., densitometry values were 391,687 ± 41,243 in HCONT and 207,492 ± 30,617 in HINFLA (n = 3, p < 0.05). CYP1A2 densitometry values were 309,098 ± 57,205 in HCONT and 205,618 ± 35,456 in HINFLA (n = 3, p > 0.05). The amount of CYP3A6 apoprotein was reduced to an undetectable level (Fig. 1).
|
|
Effect of RSCONT and RSTIAR on P450 of HCONT Following 4 and 24 h of Incubation. Incubation of RSCONT with HCONT for 4 h did not modify P450 content and ability to biotransform theophylline (n = 7) (Table 1). Compared with RSCONT, RSTIAR did not modify P450 content, and did not reduce the formation of 3 MX, 1 MU, and 1,3DMU (p > 0.05) (Table 1). Neither RSCONT nor RSTIAR affected the amount of CYP1A1, 1A2, and 3A6 apoproteins in HCONT (data not shown).
After a 24-h period of incubation with HCONT, compared with RSCONT, RSTIAR did not modify P450 content, but reduced the formation of 1 MU and 1,3DMU by 27 and 28%, respectively (p < 0.05, n = 8) (Table 1). Following 24 h of incubation with RSTIAR, the amount of CYP1A1 and 1A2 remained unchanged, i.e., densitometry values for CYP1A1 were 283,835 ± 17,818 incubated with RSCONT and 277,457 ± 19,912 with RSTIAR, and for CYP1A2 densitometry values were 305,303 ± 60,486 with RSCONT and 327,771 ± 79,745 with RSTIAR. On the other hand, by reference to RSCONT (densitometry value 492,585 ± 98,749), CYP3A6 decreased by 45% when HCONT was incubated with RSTIAR (284,232 ± 68,265) (n = 4, p < 0.05) (Fig. 2).
|
Effect of RSCONT and RSTIAR on P450 of HINFLA Following 4 and 24 h of Incubation. Following 4 h of incubation, and compared with RSCONT, RSTIAR did not reduce P450 content in HINFLA, but reduced the formation of 1 MU and 1,3DMU by 34 and 26%, respectively (p < 0.005, n = 7) (Table 2). On the other hand, the amount of CYP1A1 and 1A2 proteins was not affected in HINFLA (data not shown).
|
In Vivo Effect of an URVI on Metabolism of Theophylline in Human Volunteers. During the symptom-free period in five control volunteers, the 24-h urinary recovery of theophylline and its metabolites accounted for 69% of the dose administered, of which 13.3% was 3 MX, 20.3% 1 MU, and 52.5% was 1,3DMU. While the volunteers presented symptoms of URVI, the 24-h urinary recovery of theophylline and its metabolites decreased to 58% (p < 0.05). Compared with the control period, recovery of 3 MX, 1 MU, and 1,3DMU was decreased by 30, 29, and 14% (p < 0.05), respectively (Fig. 3).
|
Effect of HSCONT and HSURVI on P450 of HCONT Following 4 and 24 h of Incubation. Incubation of HSCONT with HCONT for 4 and 24 h did not change hepatic P450. In contrast, following 4 h of incubation, HSURVI did not modify total P450 content but decreased the formation of 1 MU and 1,3DMU by 28 and 32%, respectively (p < 0.05) (Table 3). The amounts of CYP1A1, 1A2, and 3A6 were not affected (data not shown).
|
|
Effect of HSCONT and HSURVI on P450 of HINFLA Following 4 and 24 h of Incubation. Incubation of HSURVI with HINFLA for 4 h decreased total P450 content from 0.140 ± 0.013 nmol/mg of protein to 0.101 ± 0.011 nmol/mg of protein (p < 0.05). HSURVI lowered the concentration of 1 MU and 1,3DMU by 42 and 32%, respectively (p < 0.05) (Table 3), without affecting the amount of CYP1A1 and 1A2 (data not shown).
Incubation of HSURVI with HINFLA for 24 h decreased total P450 content from 0.135 ± 0.011 nmol/mg of protein to 0.079 ± 0.009 nmol/mg of protein (p < 0.05) (n = 7), and lowered the concentration of 3 MX, 1 MU, and 1,3DMU by 40, 55, and 39%, respectively (p < 0.05) (n = 7) (Table 3). Following incubation with HSURVI, the amounts of CYP1A1 and 1A2 were reduced by 33 and 22% (p < 0.05), respectively, i.e., densitometry values for CYP1A1 were 193,520 ± 12,936 incubated with HSCONT and 125,503 ± 10,377 with HSURVI, and for CYP1A2 densitometry values were 188,124 ± 17,748 with HSCONT and 141,281 ± 10,405 with HSURVI (n = 4) (Fig. 4). Considering the five volunteers who received 300 mg of theophylline, incubation of HSURVI with HINFLA for 4 h reduced theophylline biotransformation and P450 content (data not shown), decrease that was not associated with the decrease in 24-h urinary recovery of 3 MX, 1 MU, and 1,3DMU (Fig. 3). However, the in vitro reduction in P450 content was directly associated (r2 = 0.9101) with the in vivo decrease in urinary recovery of the total amount of theophylline metabolites, i.e., 3 MX + 1 MU + 1,3DMU, supporting that the in vivo repercussions of a viral infection on drug metabolism are associated to the ability of the serum of these volunteers to reduce P450 activity.| |
Discussion |
|---|
|
|
|---|
The present study demonstrates that RSTIAR
does not affect P450 amount or activity when incubated for 4 h
with HCONT, however, it decreases P450 activity
in HINFLA. When RSTIAR is
incubated with HCONT for 24 h, P450 activity
is reduced, as well as the amount of CYP3A6 protein. Incubation of
RSTIAR with HINFLA for 24 h decreases total P450 content and activity, without affecting CYP1A1 or 1A2. Keeping in mind that theophylline is primarily biotransformed by CYP1A2 (Kurdi et al., 1999
), these results show that
RSTIAR elicits a dual effect on P450: it reduces
the activity of CYP1A1 and 1A2, and down-regulates CYP3A6.
RSTIAR effects on P450 depend upon the length of
incubation, and the state of the hepatocytes, i.e., control or primed.
The RSTIAR-induced decrease in P450 activity
could be a general phenomenon since the down-regulation of P450
isoforms by lipopolysaccharides is preceded by their inactivation
(Sewer et al., 1998
). Nitric oxide may have a pivotal role in P450
inactivation by both, the turpentine induced inflammation (El-Kadi et
al., 2000
), and lipopolysaccharide-induced endotoxemia (Sewer et al.,
1998
; Takemura et al., 1999
). The fact that the biotransformation of
theophylline and total P450 content in HINFLA are
reduced by RSTIAR without changes in the amount of CYP1A1, 1A2, and 3A6 proteins, further supports that nitric oxide
contributes to the reduction in P450 activity. As discussed, upon
binding to Fe2+ and
Fe3+-heme, nitric oxide impedes
O2 binding and as a consequence, it reduces
theophylline biotransformation. In parallel, nitric oxide binding to
Fe2+-heme impedes the binding of carbon monoxide
used for the spectrophotometric determination of total P450 content
(Omura and Sato, 1964
), resulting in the apparent decrease in total
P450 content.
Following 24-h incubation with HCONT,
RSTIAR reduction of P450 activity and CYP3A6
expression may be explained by the fact that IL-6 is the primary serum
mediator induced by the TIAR (Bleau et al., 2000
; Siewert et al.,
2000
). IL-6 preferentially depresses activity and expression of CYP3A,
with little effect on the expression of CYP1A1 and 1A2 proteins
(Muntané-Relat et al., 1995
). CYP3A6 down-regulation by IL-6 has
been associated with the decrease in the expression of pregnane X
receptor and constitutively activated receptor mRNAs (Pascussi et al.,
2000
). On the other hand, it has been shown that IL-6 increases the
expression of inducible nitric-oxide synthase (NOS2) (Ma and Zhu,
2000
). Since CYP3A6 in HINFLA is already
depressed by the TIAR, incubation of HINFLA with
RSTIAR for 24 h reduces only CYP1A1 and 1A2 activity.
When HSURVI is incubated for 4 h with HCONT, there is a decrease in P450 activity without changes in CYP1A1, 1A2, or 3A6 apoproteins; when the incubation is prolonged for 24 h, the decrease in P450 activity is accompanied by a reduction in the amount of CYP3A6. Incubation of HSURVI with HINFLA for 4 h reduces activity and total P450 content, and incubation for 24 h reduces activity, total P450 content and amount of CYP1A1 and 1A2 proteins. These experiments clearly indicate that P450 down-regulation is preceded by a decrease in activity of several P450 isoforms. As demonstrated by the in vivo studies in human volunteers, the potency of HSURVI to reduce P450 activity is directly associated with the repercussions of the viral infection on the in vivo metabolism of theophylline.
There is evidence pointing out that following the incubation of
HSURVI with HCONT and
HINFLA for 4 h, the decrease in P450 activity is also mediated by nitric oxide (El-Kadi et al., 2000
). The
decrease in P450 activity in HCONT following 4-h
incubation with HSURVI implies that the source of
nitric oxide may not be NOS2, since longer periods are required to
increase its expression. A potential source of nitric oxide in
HCONT could be CYP3A6, since this isoform is a
direct source of nitric oxide (Servent et al., 1989
; Boucher et al.,
1992
). On the other hand, in HINFLA after 4 h of incubation, the effect of HSURVI is almost
totally prevented by
N
-nitro-L-arginine
methyl ester (El-Kadi et al., 2000
), supporting that nitric oxide is
also responsible for the decrease in P450 activity. The source of
nitric oxide in HINFLA could be NOS2, because
CYP3A6 is almost completely down-regulated.
Following 24 h of incubation, HSURVI
down-regulates CYP1A1/2 in HINFLA but not in
HCONT, where only CYP3A6 is down-regulated. Possibly several factors associated to the density of surface receptors, the kind of cytokines stimulated by influenza, and the
ability of these cytokines to depress selective P450 isoforms contribute to explain these differences. In
HINFLA primed by the TIAR, the density of surface
receptors to IFN-
, IL-1
, TNF-
, and IL-6 could be increased,
since not only inflammatory stimuli increase the density of surface
receptors but also higher levels of circulating cytokines produce the
same effect (Volpes et al., 1991
; Dinarello, 1994
). In humans,
influenza increases the concentration of cytokines known to
down-regulate P450 isoforms, such as IL-1
, IL-6, TNF-
, and
IFN-
(Han and Meydani, 2000
). The ability of these cytokines to
depress CYP3A isoforms is greater than that to down-regulate CYP1A1/2
(Abdel-Razzak et al., 1993
; Muntané-Relat et al., 1995
). These
differences may be explained in part by the mechanism through which a
cytokine depresses the expression of an isoform. For example, IL-1
promotes a pretranscriptional repression, while IFN-
exerts a
post-transcriptional suppressive effect on CYP3A6 expression (Calleja
et al., 1998
), and a pretranscriptional down-regulation of CYP1A2
(Abdel-Razzak et al., 1993
), however, its effect is weak compared with
IL-1
(Calleja et al., 1997
). IL-6 is a stronger pretranscriptional
repressor of CYP3A4 mRNA than IL-1
and TNF-
, but TNF-
appears
to elicit a stronger pretranscriptional effect on CYP1A1/2 than IL-1
and IL-6 (Muntané-Relat et al., 1995
). We may postulate that
CYP3A6 expression is more sensitive to the effect of cytokines because
IL-1
, IL-6, TNF-
, and IFN-
down-regulate CYP3A6 expression
through pre- and post-transcriptional mechanisms, and CYP1A1/2 only by
a pretranscriptional repression mechanism.
In conclusion, the present study demonstrates 1) that the effect of RSTIAR and HSURVI depends upon the susceptibility of the hepatocyte (HCONT or primed HINFLA), emphasizing the importance of the model for an accurate interpretation of the results; 2) that P450 down-regulation is preceded by a decrease in P450 activity; 3) that the differences between RSTIAR and HSURVI are primarily dependent upon the mediators contained in the serum, indicating that the nature of the inflammatory reaction is of importance to determine the repercussions on P450 activity and expression; and 4) the present results confirm that CYP3A6 is more vulnerable than CYP1A1 and 1A2 to the down-regulation provoked by an inflammatory challenge, a fact that may have practical consequences when it is taken into account the relevancy of this isoform in drug metabolism.
Anne-Marie Bleau
Caroline Fradette
Ayman O. S. El-Kadi
Marie-Claude Côté
Patrick du Souich
Department of Pharmacology, Faculty of Medicine, University of
Montréal, Montréal, Québec, Canada
| |
Acknowledgments |
|---|
The technical assistance of Hélène Mauriel and Lucie Héroux is gratefully acknowledged.
| |
Footnotes |
|---|
Received December 12, 2000; accepted March 20, 2001.
This study was supported by a grant from the Canadian Institutes of Health Research (MOP-43925).
Patrick du Souich, M.D., Ph.D., Department of Pharmacology, Faculty of Medicine, University of Montréal, P.O. Box 6128, Stat. Center-Ville, Montréal, Québec, Canada H3C 3J7. E-mail: patrick.du.souich{at}umontreal.ca
| |
Abbreviations |
|---|
Abbreviations used are:
P450, cytochrome P450;
IFN, interferon;
CYP, apoprotein of the cytochrome P450;
IL, interleukin;
TNF-
, tumor necrosis factor-
;
HSURVI, serum from human with an upper respiratory viral infection;
TIAR, turpentine-induced acute inflammatory reaction;
RSTIAR, serum from rabbits with a turpentine-induced acute inflammatory
reaction;
HINFLA, hepatocytes from rabbit with a
turpentine-induced acute inflammatory reaction;
HCONT, hepatocytes from control rabbit;
3 MX, 3-methylxanthine;
1 MU, 1-methyluric acid;
1,3DMU, 1,3-dimethyluric acid;
RSCONT, serum from control rabbits;
HSCONT serum from control volunteers, URVI, upper respiratory viral infection;
NOS, nitric-oxide
synthase.
| |
References |
|---|
|
|
|---|
in human hepatocytes.
J Pharmacol Exp Ther
281:
484-490
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||